Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer
2012 · Radiation Oncology · 37 citations
https://doi.org/10.1186/1748-717x-7-154
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
532
Citations
9
h-index
8
i10-index
Kathleen A. Bridges is an academic researcher from University of Arkansas at Monticello. The author has contributed to research in topics: Cancer-related Molecular Pathways & Histone Deacetylase Inhibitors Research & Epigenetics and DNA Methylation. The author has an h-index of 9, co-authored 41 publications.
https://doi.org/10.1186/1748-717x-7-154
https://doi.org/10.1038/s41467-021-26570-8
https://doi.org/10.1016/j.ecolind.2024.112759
Click to start Chat